Innovex Fc Receptor Blocker

Innovex FC Receptor

Fc Receptor Blocker is a ought to for proper lymphoma, leukemia and melanoma typing and as well as for Background-free Kappa and lambda staining

 

Does NOT embody antibodies, serum, immunoglobulins, immunoglobulin fragments or enzymes.

Moreover obtainable in azide-free for keep cell, helpful assays and Stream cytometry. Fc Blocker might be utilized for keep cells and helpful assays which is likely to be delicate to sodium azide with none cytotoxicity or cell demise.
Azide-Free Fc Blocker can be used for Stream cytometry.

INNOVEX BIOSCIENCES Fc Receptor
INNOVEX BIOSCIENCES Fc Receptor

Innovex Fc Receptor Block is a peptide based experience designed to dam Fc Receptors present on all leukocytes (white blood cells), lymphomas, leukemias and melanomas. Fc receptors are moreover expressed on a majority of tumors; Blocking the Fc receptors is vital for proper typing of lymphoid and tumor tissues and cells. Fc receptor staining occurs by the binding of Fc receptors present on cells to the Fc space of the primary and/or secondary antibody and isotype controls.

ADVANCED AND UNIQUE FEATURES

  • Blocks Fc Receptors in every human and animal cells
  • 30 minute incubation step at room temperature for human tissues/cells
  • 45 minutes to 1-hour incubation for animal tissues/cells
  • Eliminates false constructive staining of white blood cells, lymphoid tissues, cytosmears (blood & bone marrow), melanoma tumors and completely different Fc expressing tumors
  • Insures right lymphoma and leukemia typing
  • liminates unfavorable administration staining of lymphomas, lymphoid tissues, and blood and bone marrow smears
  • Eliminates false constructive staining for Kappa and Lambda staining
  • Eliminates false constructive staining of Reed Sternberg cells
  • A ought to for CD markers staining in IHC, immunofluorescence
  • A ought to for CD phenotyping by the use of circulation cytometry
  • A ought to for Immunoglobulins (Igs) staining by the use of IHC, circulation cytometry and immunofluorescence
  • A ought to for kappa and lambda staining

Fc Receptor Blocker; 4X Concentrate, 40 ml Concentrate

NB309-4X-40 40 ml of 4X concentrate
EUR 1655

Fc Receptor Blocker, 5 ml (trial size); Ready-To-Use

NB309-5S 5 ml
EUR 159

Innovex Nuclear Red counterstain (permanent), 10 ml

NB326 10 ml
EUR 165

Azide-Free Fc Receptor Blocker, 60 ml (Large volume) Ready-To-Use

NB335-60 60 ml
EUR 795

Azide-Free Fc Rreceptor Blocker, 30 ml (Small volume) Ready-To-Use

NB335 30 ml
EUR 490

Androgen Receptor Antibody, Concentrate

MAB520C 0.2ml
EUR 565

Vitamin D Receptor Antibody, Concentrate

MAB507C 0.2ml
EUR 495

Estrogen Receptor(ED1D5) Antibody, Concentrate

MAB323C 0.2ml
EUR 785

Progesterone Receptor (PR) Antibody, Concentrate

MAB380C 0.2ml
EUR 685

CD71,Transferrin Receptor Antibody, Concentrate

MAB770C 0.2ml
EUR 485

CD25,(Interleukin-2 Receptor) Antibody, Concentrate

MAB535C 0.2ml
EUR 435

Estrogen Receptor, (ED1D5) Antibody, Ready-To-Use

MAB323P 5ml
EUR 785

Progesterone Receptor, (PR) Antibody, Ready-To-Use

MAB380P 5ml
EUR 645

CD71,Transferrin Receptor Antibody, Ready-To-Use

MAB770P 5ml
EUR 465

CD25,(Interleukin-2 Receptor) Antibody, Ready-To-Use

MAB535P 5ml
EUR 425

Epidermal Growth Factor Receptor (EGFR) Antibody, Concentrate

MAB325C 0.2ml
EUR 465

Epidermal Growth Factor Receptor (EGFR) Antibody, Ready-To-Use

MAB325P 5ml
EUR 445

Peroxidase Block (Stable); Ready-To-Use, 10 ml

HP1000-10 10ml
EUR 95

Peroxidase Block (Stable); Ready-To-Use, 500 ml

HP1000-500 500 ml
EUR 395

Peroxidase Block (Stable); Ready-To-Use, 60 ml

HP1000-60 60 ml
EUR 195

Immuno Diluent and Block (clear solution) for diluting and indefinate storage of antibodies, 125 ml of Ready-To-Use

NB307-C 125 ml
EUR 385

Immuno Diluent and Block (clear solution) for diluting and indefinate storage of antibodies, 50 ml of Ready-To-Use

NB307-C-50 50 ml
EUR 290

Hen Blocker

CH23106 100 ml
EUR 434.4

NaV1.7 blocker-801

HY-116194 Get quote Ask for price
Description: NaV1.7 blocker-801 is a NaV1.7 channel blocker that can be used in the study of neurological diseases[1].

Leave a Reply

Your email address will not be published. Required fields are marked *

Blog PCR

Human monkeypox – After 40 years, an unintended consequence of smallpox eradication

Smallpox eradication, coordinated by the WHO and certified 40 years ago, led to the cessation of routine smallpox vaccination in most countries. It is estimated that over 70% of the world’s population is no longer protected against smallpox, and through cross-immunity, to closely related orthopox viruses such as monkeypox. Monkeypox is now a re-emerging disease. […]

Read More
Blog parg antibody

A Tale of Two Viruses: Coinfections of Monkeypox and Varicella Zoster Virus in the Democratic Republic of Congo

Recent enhanced monkeypox (MPX) surveillance in the Democratic Republic of Congo, where MPX is endemic, has uncovered multiple cases of MPX and varicella zoster virus (VZV) coinfections. The purpose of this study was to verify if coinfections occur and to characterize the clinical nature of these cases. Clinical, epidemiological, and laboratory results were used to […]

Read More